These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7065435)

  • 1. Thiopental disposition in lean and obese patients undergoing surgery.
    Jung D; Mayersohn M; Perrier D; Calkins J; Saunders R
    Anesthesiology; 1982 Apr; 56(4):269-74. PubMed ID: 7065435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiopental disposition as a function of age in female patients undergoing surgery.
    Jung D; Mayersohn M; Perrier D; Calkins J; Saunders R
    Anesthesiology; 1982 Apr; 56(4):263-8. PubMed ID: 7065434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased protein binding and thiopental kinetics.
    Burch PG; Stanski DR
    Clin Pharmacol Ther; 1982 Aug; 32(2):212-7. PubMed ID: 7094508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopental pharmacokinetics in patients with cirrhosis.
    Pandele G; Chaux F; Salvadori C; Farinotti M; Duvaldestin P
    Anesthesiology; 1983 Aug; 59(2):123-6. PubMed ID: 6869869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and plasma binding of thiopental. I: Studies in surgical patients.
    Morgan DJ; Blackman GL; Paull JD; Wolf LJ
    Anesthesiology; 1981 Jun; 54(6):468-73. PubMed ID: 7235274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of thiopental in pediatric surgical patients.
    Sorbo S; Hudson RJ; Loomis JC
    Anesthesiology; 1984 Dec; 61(6):666-70. PubMed ID: 6507924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section.
    Morgan DJ; Blackman GL; Paull JD; Wolf LJ
    Anesthesiology; 1981 Jun; 54(6):474-80. PubMed ID: 7235275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer simulation of the effects of alterations in blood flows and body composition on thiopental pharmacokinetics in humans.
    Wada DR; Björkman S; Ebling WF; Harashima H; Harapat SR; Stanski DR
    Anesthesiology; 1997 Oct; 87(4):884-99. PubMed ID: 9357892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
    Todd EL; Abernethy DR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of thiopental in patients undergoing renal transplantation.
    Christensen JH; Andreasen F; Jansen J
    Acta Anaesthesiol Scand; 1983 Dec; 27(6):513-8. PubMed ID: 6364679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulfadimethoxine on thiopental distribution and elimination in rats.
    Yu HY; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Sci; 1981 Mar; 70(3):323-6. PubMed ID: 7264902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin pharmacokinetics in normal and morbidly obese subjects.
    Blouin RA; Bauer LA; Miller DD; Record KE; Griffen WO
    Antimicrob Agents Chemother; 1982 Apr; 21(4):575-80. PubMed ID: 7081978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity on sulfonamide disposition in Zucker rats.
    Kaul S; Ritschel WA
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):273-83. PubMed ID: 3243323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties of thiopental in two patients treated for uncontrollable seizures.
    Cloyd JC; Wright BD; Perrier D
    Epilepsia; 1979 Jun; 20(3):313-8. PubMed ID: 109293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrient oxidation patterns and protein metabolism in lean and obese subjects.
    Bruce AC; McNurlan MA; McHardy KC; Broom J; Buchanan KD; Calder AG; Milne E; McGaw BA; Garlick PJ; James WP
    Int J Obes; 1990 Jul; 14(7):631-46. PubMed ID: 2228398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Eur J Clin Pharmacol; 1995; 47(6):525-30. PubMed ID: 7768256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of thiopentone.
    Brandon RA; Baggot JD
    J Vet Pharmacol Ther; 1981 Jun; 4(2):79-85. PubMed ID: 7349330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug disposition in obese humans. An update.
    Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 1986; 11(3):199-213. PubMed ID: 3524955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of body weight on dalteparin pharmacokinetics. A preliminary study.
    Yee JY; Duffull SB
    Eur J Clin Pharmacol; 2000 Jul; 56(4):293-7. PubMed ID: 10954342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.